Medicare Enrolled
Dr. Anthony Lomonaco, D.O.
Pain Medicine · Beverly, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lomonaco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lomonaco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lomonaco
Dr. Anthony Lomonaco is a pain medicine specialist in Beverly, MA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lomonaco performed 6,904 Medicare services across 1,999 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lomonaco received a total of $21,669 from 42 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lomonaco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 7% volume in MA
$21,669 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,904
Medicare services
Top 7% in MA for pain medicine
1,999
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~384 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,443 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,290 | $100 | $375 |
| Contrast dye for imaging, lower concentration | 204 | $0 | $50 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
171 | $60 | $180 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
162 | $0 | $35 |
| Injection, fentanyl citrate, 0.1 mg | 118 | $1 | $20 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
116 | $1 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $130 | $850 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
102 | $26 | $262 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
95 | $204 | $2,000 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
95 | $105 | $2,000 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $74 | $300 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
66 | $215 | $2,000 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
63 | $50 | $500 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
62 | $521 | $2,540 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
59 | $303 | $2,542 |
| Injection, propofol, 10 mg | 59 | $0 | $34 |
| Anesthesia for spine nerve destruction procedure Administration of anesthesia during a procedure to destroy nerves in the lower back or spinal cord, guided by imaging. |
57 | $89 | $3,581 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
54 | $168 | $2,815 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
45 | $232 | $2,400 |
| Anesthesia for nerve block and injection, prone position Administration of anesthesia during a nerve block or injection procedure while the patient is lying face down. |
42 | $96 | $3,776 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
38 | $201 | $2,000 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
38 | $103 | $2,000 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
34 | $60 | $1,025 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
33 | $221 | $2,000 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
33 | $274 | $3,500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $137 | $450 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
29 | $97 | $2,000 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
28 | $491 | $2,500 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
27 | $301 | $2,500 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
27 | $60 | $400 |
| Anesthesia for eyelid procedure Administration of anesthesia during a surgical procedure involving the eyelid. |
21 | $132 | $4,983 |
| Anesthesia for nerve block and injection Administration of anesthetic medication to numb a specific nerve or area during a nerve block or injection procedure. |
16 | $67 | $2,519 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
16 | $71 | $1,169 |
| Spinal neurostimulator generator insertion Surgical placement of a spinal neurostimulator generator or receiver device. |
16 | $216 | $3,500 |
| Anesthesia for shock wave therapy for urinary stones Administration of anesthesia during shock wave lithotripsy to break up urinary system stones without the use of a water bath. |
13 | $128 | $4,950 |
| Anesthesia for spine nerve destruction procedure Anesthesia provided during a procedure to destroy nerves in the neck or upper back spine. The procedure is performed through the skin using imaging guidance. |
13 | $93 | $3,650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,669
Total received (2018-2024)
Avg $3,096/year across 7 years
Top 14% in MA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,084 (60.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,585 (39.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$628
2023
$1,100
2022
$1,868
2021
$731
2020
$1,313
2019
$3,116
2018
$12,912
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$329
PAINTEQ LLC
$99
SI-BONE, INC.
$75
Vertos Medical, Inc.
$61
Abbott Laboratories
$47
ConvaTec Inc.
$17
Top 3 companies account for 80.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$14,522
Vertos Medical, Inc.
$1,308
Spinal Simplicity, LLC
$1,090
Vertiflex, Inc.
$864
Boston Scientific Corporation
$578
PAINTEQ LLC
$523
Relievant Medsystems, Inc.
$469
Stimwave Technologies Incorporated
$378
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$294
BIONESS INC
$158
Collegium Pharmaceutical, Inc.
$155
Nevro Corp.
$134
Medtronic, Inc.
$113
SI-BONE, INC.
$75
ABBVIE INC.
$74
Bioventus LLC
$71
Scilex Pharmaceuticals Inc.
$71
PFIZER INC.
$64
Purdue Pharma L.P.
$63
Kaleo, Inc.
$59
Novartis Pharmaceuticals Corporation
$58
Saluda Medical Americas, Inc.
$53
Shionogi Inc
$45
SCILEX PHARMACEUTICALS INC.
$42
Teva Pharmaceuticals USA, Inc.
$41
Amneal Pharmaceuticals LLC
$36
IBSA Pharma Inc.
$36
Amgen Inc.
$27
BioDelivery Sciences International, Inc.
$25
SI-BONE, Inc.
$25
Pacira Pharmaceuticals Incorporated
$24
Daiichi Sankyo Inc.
$23
Nalu Medical, Inc.
$23
Ultragenyx Pharmaceutical Inc.
$22
Allergan Inc.
$21
RedHill Biopharma Inc.
$19
ConvaTec Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$16
Pernix Therapeutics Holdings, Inc.
$14
Zyla Life Sciences
$13
Medtronic USA, Inc.
$13
INSYS Therapeutics Inc
$13
Top 3 companies account for 78.1% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AQUACEL AG+ EXTRA · AXIUM · Aimovig · Axium INS DRG IPG · Axium Sheath Braided DRG · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · CFNS StimQ Peripheral Nerve StimulatorSystem · Crysvita · DRG IPGs · DRG leads · Durolane · ETERNA · EVZIO · EXPAREL · Evoke SCS · Evzio · GENERAL PAIN MANAGEMENT · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LICART · LYRICA · LYVISPAH · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · OXYCONTIN · Octrode SCS Leads · PAINTEQ · PROCLAIM · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · RELISTOR · RELISTOR ORAL · S-Series SCS Leads · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRIX · SUBSYS · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Stimrouter for Pain · Superion ISS · Superion Indirect Decompression System · Swift-Lock SCS · Symproic · XTAMPZA · XTAMPZAER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Pain medicines within 10 mi
55
Per 100K population
6.8
County median income
$99,431
Nearest hospital
NORTHEAST HOSPITAL CORPORATION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lomonaco is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MA), with consulting-driven industry engagement in the top 14% of MA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lomonaco experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Lomonaco performed 3,443 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lomonaco receive payments from pharmaceutical companies?
Yes. Dr. Lomonaco received a total of $21,669 from 42 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lomonaco's costs compare to other pain medicines in Beverly?
Dr. Lomonaco's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lomonaco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Beverly
Browse pain medicines in Beverly ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in MA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in MA
Which MA pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Vertos Medical, Inc. Payments to Doctors
See all physicians who received payments from Vertos Medical, Inc.
By company
Spinal Simplicity, LLC Payments to Doctors
See all physicians who received payments from Spinal Simplicity, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology